Mutations in the hepatocyte nuclear factor-1a (HNF1a) gene and HNF-4a gene cause maturity onset diabetes of the young (MODY)-3 [1] and MODY1 [2], respectively. Hepatocyte nuclear factor-1a belongs to a family of homeodomain-containing transcription factors and its expression is regulated by . Clinical studies have shown MODY1 and MODY3 are caused predominantly by insulin secretory failure [4,5]. When insulin secretion was examined in stepped glucose infusion studies [4,5], non-diabetic MODY1 and MODY3 mutation carriers showed reduced insulin secretory responses to glucose. Conversely, another report showed that in a non-diabetic carrier of the MODY3 mutation, the insulin secreto- Diabetologia (1999)
AbstractAims/hypothesis. To explain the mechanisms whereby mutations in the HNF-1a gene cause insulin secretory defects. Methods. A truncated mutant HNF-1a (HNF1a288 t) was overexpressed in hepatoma cells (HepG2) and murine insulinoma cells (MIN6) using a recombinant adenovirus system and expression of the HNF-1a target genes and insulin secretion were examined. Results. Expression of phenylalanine hydroxylase and a1-antitrypsin genes, the target genes of HNF1a, was suppressed in HepG2 cells by overexpression of HNF-1a288 t. In MIN6 cells, overexpression of HNF-1a288 t did not change insulin secretion stimulated by glucose (5 mmol/l and 25 mmol/l) or leucine (20 mmol/l). Potentiation of insulin secretion by arginine (20 mmol/l, in the presence of 5 mmol/l or 25 mmol/l glucose) was, however, reduced (p < 0.0001 and p = 0.027, respectively). Similarly reduced responses were observed when stimulated with homoarginine. Expression of the cationic amino acid transporter-2 was not reduced and insulin secretory response to membrane depolarization by 50 mmol/l KCl was intact. Conclusion/interpretation. The HNF-1a288 t, which is structurally similar to the mutant HNF-1a expressed from the common MODY3 allele, P291fsinsC, exerts a dominant negative effect. Suppression of HNF-1a in MIN6 cells severely impaired potentiation of insulin secretion by arginine, whereas glucose-stimulated and leucine-stimulated insulin secretion was intact. Our findings delineate the complex nature of betacell failure in patients with MODY3. This cell model will be useful for further investigation of the mechanism of insulin secretory defects in these patients. [Diabetologia (1999) 42: 887±891] Keywords MODY, hepatocyte nuclear factor-1a, recombinant adenovirus, MIN6 cells, dominant negative effect, arginine. Received: 30 November 1998 and in revised form: 16 February 1999 Corresponding author: Y. Tanizawa, MD, PhD, Third Department of Internal Medicine, Yamaguchi University, School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755±8505, Japan Abbreviations: MODY, Maturity onset diabetes of the young; HNF, hepatocyte nuclear factor; MIN6±288 t, MIN6 cells overexpressing HNF-1a288t; MIN6-lacZ, MIN6 cells overexpressing b-galactosidase; CAT, cationic amino acid transporter; PAH, phenylalanine hydroxylase; a1-AT, a1-antitrypsin; KRB-HB, HEP...